Kevin Contrera and Stephen Lai on NRG Oncology Trial HN006
The American Head and Neck Society shared on X:
“Dr. Kevin Contrera interviews Dr. Stephen Lai on NRG Oncology Trial HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer. Update on its importance to our field.
Source: The American Head and Neck Society/X
Dr. Kevin Contrera is an Assistant Professor of Head and Neck Surgery at UPMC. He is actively involved with the American Academy of Otolaryngology, serving as a member of the Head and Neck Surgery and Oncology Committee, as well as the Head and Neck Surgery Education Committee. Additionally, he contributes to the American Head and Neck Society, where he is part of the Practice Guidelines and Position Statements Service and the Population Health and Clinical Research Service.
Stephen Y. Lai, M.D., Ph.D., is a Professor of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center and a board-certified head and neck cancer surgeon. He also serves as the Quality Officer for the Department of Head and Neck Surgery. His clinical expertise includes the treatment of head and neck cancers, with a focus on oral cavity cancer, thyroid and parathyroid disorders, salivary gland neoplasms, conservation laryngeal surgery, and stereotactic radiosurgery.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023